Analyst Expectations For Sarepta Therapeutics's Future
Analyst Expectations For Sarepta Therapeutics's Future
分析師對sarepta therapeutics未來的期望
The standing of...14 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，有14位分析師對Sarepta Therapeutics（納斯達克股票代碼：SRPT）表達了各種看法，從看漲到看跌，提出了各種各樣的觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的評級，展示了過去30天情緒的演變，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $168.79, a high estimate of $205.00, and a low estimate of $80.00. Experiencing a 5.56% decline, the current average is now lower than the previous average price target of $178.73.
分析師爲Sarepta Therapeutics設定了12個月的目標股價，顯示平均目標股價爲168.79美元，最高估計爲205.00美元，低估值爲80.00美元。目前的平均價格下降了5.56％，現在低於之前的平均目標股價178.73美元。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
The standing of...
通過對...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間